Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.475 USD | -0.76% |
|
-11.86% | -18.48% |
Jun. 17 | Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy | MT |
Jun. 17 | Zymeworks Gets FDA OK to Study ZW171 for Mesothelin-Expressing Cancers | DJ |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bearish | Neutral |
Resistance | 9.610 | 10.52 | 12.51 |
Spread/Res. | -11.86% | -19.49% | -32.29% |
Spread/Supp. | +0.65% | +4.44% | +33.60% |
Support | 8.415 | 8.110 | 6.340 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ZYME Stock
- Charts Zymeworks Inc.